US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3145

+0.01284.24%

Post-market: 0.3100-0.0045-1.43%19:47 EDT

Volume:4.33M

Turnover:1.41M

Market Cap:22.36M

PE:-0.92

High:0.3200

Open:0.3170

Low:0.2888

Close:0.3017

Loading ...

Overview Company News Filings

Ovid Therapeutics Sells Future Ganaxolone Royalties to Immedica Pharma for $7 Million

Ovid Therapeutics Enters Agreement With Immedica Pharma Ab for Sale of Future Ganaxolone Royalties

THOMSON REUTERS

Ovid Therapeutics Inc. Unveils Corporate Presentation Highlighting Precision Small Molecule Programs and Differentiated Pipeline for Neurological Disorders

Ovid Therapeutics Inc. to Host Investor and Media Event on Emerging Epilepsy Biomarkers and OV329 Program Highlights

Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Ovid Therapeutics Q1 EPS $(0.14), Inline, Sales $130.00K Beat $50.00K Estimate

BRIEF-Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million

Ovid Therapeutics Reports Q1 2025 Net Loss of $10.2M, EPS Improves to $0.14 as Revenues Slip to $130K

Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million

THOMSON REUTERS

Press Release: Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Ovid Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Ovid Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $2 From $3

THOMSON REUTERS

William Blair Sticks to Their Buy Rating for Ovid Therapeutics (OVID)

Ovid Therapeutics’ Cybersecurity Challenges: Navigating IT Risks and Third-Party Dependencies

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Ovid Therapeutics Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate

Press Release: Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate

Simply Wall St.

Ovid Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OVID/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OVID","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OVID\",,,,,undefined,":{"symbol":"OVID","market":"US","secType":"STK","nameCN":"Ovid Therapeutics Inc.","latestPrice":0.3145,"timestamp":1750881600000,"preClose":0.3017,"halted":0,"volume":4332196,"hourTrading":{"tag":"盘后","latestPrice":0.31,"preClose":0.3145,"latestTime":"19:47 EDT","volume":69942,"amount":21720.527958,"timestamp":1750895229048},"delay":0,"floatShares":50354716,"shares":71109514,"eps":-0.342863,"marketStatus":"Not Yet Opened","change":0.0128,"latestTime":"06-25 16:00:00 EDT","open":0.317,"high":0.32,"low":0.2888,"amount":1413669.89528336,"amplitude":0.103414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.342863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750924800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1493956800000,"exchange":"NASDAQ","adjPreClose":0.3017,"preHourTrading":{"tag":"盘前","latestPrice":0.3161,"preClose":0.3017,"latestTime":"09:29 EDT","volume":1546705,"amount":527597.54790825,"timestamp":1750858194064},"postHourTrading":{"tag":"盘后","latestPrice":0.31,"preClose":0.3145,"latestTime":"19:47 EDT","volume":69942,"amount":21720.527958,"timestamp":1750895229048},"volumeRatio":5.400215,"impliedVol":1.0754,"impliedVolPercentile":0.892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OVID\",,,,,undefined,":{"symbol":"OVID","floatShares":50354716,"roa":"-31.37%","roe":"-36.31%","lyrEps":-0.366333,"volumeRatio":5.400215,"shares":71109514,"dividePrice":0,"high":0.32,"amplitude":0.103414,"preClose":0.3017,"low":0.2888,"week52Low":0.2425,"pbRate":"0.38","psRate":"40.81","week52High":1.47,"institutionHeld":0,"latestPrice":0.3145,"eps":-0.342863,"divideRate":0,"volume":4332196,"delay":0,"ttmEps":-0.342863,"open":0.317,"prevYearClose":0.9337,"prevWeekClose":0.3104,"prevMonthClose":0.2722,"prevQuarterClose":0.3119,"fiveDayClose":0.3024,"twentyDayClose":0.2914,"sixtyDayClose":0.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OVID\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546217529","title":"Ovid Therapeutics Sells Future Ganaxolone Royalties to Immedica Pharma for $7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2546217529","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546217529?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:01","pubTimestamp":1750852866,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. has announced an agreement with Immedica Pharma AB for the sale of its future royalties related to sales of ganaxolone outside China. The transaction provides Ovid with a non-dilutive capital infusion of $7 million, which will support its ongoing operations. Immedica will acquire 100% of the royalty rights held by Ovid and assume financial responsibility for certain intellectual property costs related to ganaxolone. This agreement strengthens Immedica's focus on ganaxolone by acquiring control of additional intellectual property rights.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on June 25, 2025, and is s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL5NyrGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4588","LU2210149790.SGD","OVID","BK4139","NDAQ","BK4585","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2546421788","title":"Ovid Therapeutics Enters Agreement With Immedica Pharma Ab for Sale of Future Ganaxolone Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2546421788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546421788?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:00","pubTimestamp":1750852800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nTUA3FXDXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2543154036","title":"Ovid Therapeutics Inc. Unveils Corporate Presentation Highlighting Precision Small Molecule Programs and Differentiated Pipeline for Neurological Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2543154036","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543154036?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:06","pubTimestamp":1749762361,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. Unveils Corporate Presentation Highlighting Precision Small Molecule Programs and Differentiated Pipeline for Neurological Disorders. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief on June 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL9jj2GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2541050022","title":"Ovid Therapeutics Inc. to Host Investor and Media Event on Emerging Epilepsy Biomarkers and OV329 Program Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2541050022","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541050022?lang=en_us&edition=fundamental","pubTime":"2025-06-05 19:30","pubTimestamp":1749123041,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc., a biopharmaceutical company focused on brain conditions with unmet needs, will host an investor and media event on Thursday, June 12, 2025. The event will center on the application of biomarkers in epilepsy, specifically showcasing the pharmacodynamic activity of their OV329 clinical development program. This program involves a next-generation GABA-aminotransferase inhibitor aimed at providing a novel approach for treatment-resistant seizures. The event will feature insights from Dr. Alexander Rotenberger and will be available via a live webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on June 05, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL9jlLqb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","NDAQ"],"gpt_icon":0},{"id":"2535792237","title":"Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535792237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535792237?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:31","pubTimestamp":1747143077,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryOvid Therapeutics Inc OVID.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID"],"gpt_icon":0},{"id":"2535727011","title":"Ovid Therapeutics Q1 EPS $(0.14), Inline, Sales $130.00K Beat $50.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727011","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727011?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:10","pubTimestamp":1747138238,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 17.65 percent increase over losses of $(0.17) per share from the same period last year. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45373313/ovid-therapeutics-q1-eps-0-14-inline-sales-130-00k-beat-50-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","LENZ"],"gpt_icon":0},{"id":"2535727995","title":"BRIEF-Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727995?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137648,"startTime":"0","endTime":"0","summary":"BRIEF-Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million\n\n\nMay 13 (Reuters) - Ovid Therapeutics Q1 net income USD -10.235 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX60B9BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID"],"gpt_icon":0},{"id":"2535727904","title":"Ovid Therapeutics Reports Q1 2025 Net Loss of $10.2M, EPS Improves to $0.14 as Revenues Slip to $130K","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727904","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727904?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137620,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc., a biopharmaceutical company focused on developing treatments for brain conditions, announced its financial results for the first quarter of 2025. As of March 31, 2025, the company reported $43.0 million in cash, cash equivalents, and marketable securities. Revenues from royalty agreements were $130,000, reflecting a decrease from $148,000 in the same period the previous year. The company reported a net loss of $10.2 million for the first quarter, compared to a net loss of $11.7 million during the same period in 2024. Research and development expenses were reduced to $6.7 million from $10.4 million in the prior year's first quarter, attributed to organizational restructuring. General and administrative expenses also decreased to $6.0 million from $7.2 million in 2024, driven by cost-reduction efforts. Total operating expenses were reported at $12.7 million, down from $17.6 million in the previous year. In terms of business updates, Ovid's lead program, OV329, is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL5f9XfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","OVID"],"gpt_icon":0},{"id":"2535258722","title":"Ovid Therapeutics Q1 Operating Expenses USD 12.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535258722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535258722?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX60B9BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2535899727","title":"Press Release: Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535899727","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535899727?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137600,"startTime":"0","endTime":"0","summary":"-- Topline pharmacodynamic biomarker, safety and tolerability results from a. Phase 1 study of OV329 are on track to readout in Q3 2025. -- Ovid's first program in its KCC2 direct activator library, OV350, has. been dosed in a Phase 1 study in Q1 2025; safety and tolerability results. March 31, 2025 are expected to support currently planned operations and. NEW YORK, May 13, 2025  -- Ovid Therapeutics Inc. , a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today reported business updates and financial results for the first quarter ended March 31, 2025.OV329, a next-generation GABA-AT inhibitor, is anticipated to readout topline results in Q3 2025. Ovid is developing OV329 for the potential treatment of drug-resistant epilepsies . OV329 was rationally designed to endogenously deliver optimal levels of GABA to reduce seizures and provide a preferable safety and tolerability profile relative to vigabatrin, a firs","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","OVID","LU1169589451.USD","BK4007","BK4181","BK4539","LU1169590202.USD","BK4139","PD","LENZ","PK","BK4023"],"gpt_icon":0},{"id":"2534143410","title":"Ovid Therapeutics Inc  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534143410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534143410?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:34","pubTimestamp":1746804844,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc  expected to post a loss of14cents a share - Earnings Preview Ovid Therapeutics Inc OVID.OQ OVID.O is expected to show a fall in quarterly revenue when it reports  results on May","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID"],"gpt_icon":0},{"id":"2521712513","title":"Ovid Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $2 From $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2521712513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521712513?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:06","pubTimestamp":1742810760,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nAZN3LPH88:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2518529068","title":"William Blair Sticks to Their Buy Rating for Ovid Therapeutics (OVID)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518529068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518529068?lang=en_us&edition=fundamental","pubTime":"2025-03-12 16:17","pubTimestamp":1741767457,"startTime":"0","endTime":"0","summary":"In a report released today, Sarah Schram from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-ovid-therapeutics-ovid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-ovid-therapeutics-ovid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OVID"],"gpt_icon":0},{"id":"2518037575","title":"Ovid Therapeutics’ Cybersecurity Challenges: Navigating IT Risks and Third-Party Dependencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518037575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518037575?lang=en_us&edition=fundamental","pubTime":"2025-03-12 14:01","pubTimestamp":1741759295,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics (OVID) has disclosed a new risk, in the Cyber Security category. Ovid Therapeutics faces significant business risks stemming from...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ovid-therapeutics-cybersecurity-challenges-navigating-it-risks-and-third-party-dependencies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ovid-therapeutics-cybersecurity-challenges-navigating-it-risks-and-third-party-dependencies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","OVID","BK4139"],"gpt_icon":0},{"id":"2518723401","title":"Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2518723401","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518723401?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:10","pubTimestamp":1741698603,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics  came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.75%. A quarter ago, it was expected that this company would post a loss of $0.19 per share when it actually produced a loss of $0.20, delivering a surprise of -5.26%.Ovid Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.08 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 45.71%. This compares to year-ago revenues of $0.14 million. The company has topped consensus revenue estimates three times over the last four quarters.Ovid Therapeutics shares have lost about 47.6% since the beginning of the year versus the S&P 500's decline of -4.5%.While Ovid Therapeutics has underperformed the market so far this year, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ovid-therapeutics-ovid-reports-q4-131003037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OVID"],"gpt_icon":0},{"id":"2518274807","title":"Ovid Therapeutics Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274807","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518274807?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:13","pubTimestamp":1741695194,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44244374/ovid-therapeutics-q4-2024-gaap-eps-0-13-beats-0-16-estimate-sales-76k-miss-189-286k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","LENZ"],"gpt_icon":0},{"id":"2518748696","title":"Press Release: Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748696?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"-- Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to. Board of Directors; two industry veterans joined management team as Ovid. prepares to take OV329 into patient trials and move its first KCC2 direct. -- Topline results from Phase 1 study of OV329 expected in Q3 2025, which. will include biomarkers that measure clinical effect and target. -- OV350, Ovid's first program in its KCC2 direct activator library,Ovid expects its cash runway to support operations and clinical development programs into the second half of 2026, during which time multiple pipeline and regulatory milestones are anticipated. These anticipated milestones include: results for OV329 biomarker and safety data ; initiation of a Phase 2a patient study for OV329 in drug resistant epilepsies ; results from a first-in-human safety and exploratory biomarker study with OV350, our first KCC2 direct activator ; and initiation of human trials for the first oral KCC2 direct activator, OV4071 . In the eve","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","A","LU0347712357.USD","OVID","BK4567","IE00BN0W2W23.USD","LU1721428933.USD","LU1165135440.EUR","BK4181","LENZ","LU1543694498.USD","BK4585","PK","CNS","BK4121","LU2092937221.SGD","BK4218","LU2413666426.HKD","LU2413666699.HKD","IE00BN0W2T93.GBP","BK4135","IE00BN0W2V16.EUR","LU2041044095.USD","BK4588"],"gpt_icon":0},{"id":"2518717813","title":"We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717813","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518717813?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:24","pubTimestamp":1741688694,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.Given this risk, we thought we'd take a look at whether Ovid Therapeutics  shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Let's start with an examination of the business' cash, relative to its cash burn.Ovid Therapeutics' cash burn of US$58m is about 157% of its US$37m market capitalisation. That suggests the company may have some funding","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/were-little-worried-ovid-therapeutics-102454770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","OVID","QLD","NVIW.SI","USAW.SI",".IXIC","IE00B3QW5Z07.USD","BK4139","LU2210149790.SGD","PSQ","BK4588","IE00BKPKM429.USD","TQQQ","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","USJW.SI","TSYW.SI","MNQmain","NQmain","IE00B64PRP62.GBP","QQQ","NDAQ","BK4112","QID","LU2095319765.USD"],"gpt_icon":0},{"id":"2516693674","title":"Ovid Therapeutics Inc  expected to post a loss of 17 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2516693674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516693674?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:11","pubTimestamp":1741097468,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc  expected to post a loss of17cents a share - Earnings Preview Ovid Therapeutics Inc OVID.OQ OVID.O is expected to show a rise in quarterly revenue when it reports  results on Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL5N3PN1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","NYC"],"gpt_icon":0},{"id":"2516308631","title":"BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308631","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516308631?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:18","pubTimestamp":1741011514,"startTime":"0","endTime":"0","summary":"BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of DirectorsMarch 3 (Reuters) - Ovid Therapeutics Inc OVID.O:OVID THERAPEUTICS APPOINTS PIONEERING INDUSTR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA19XYGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OVID\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"OVID","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-11","symbol":"OVID","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-11-12","symbol":"OVID","fiscalQuarterEnding":"2024/09","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-08-13","symbol":"OVID","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":0.12},{"market":"US","date":"2024-05-14","symbol":"OVID","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OVID\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OVID\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.4286,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5714,"analysts":7,"updateTime":1738209600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OVID\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OVID","date":"2025-06-24","current":-0.825729,"percent":0.774167,"low":-6.494186,"twenty":-4.730126,"median":-2.332461,"eighty":1.513783,"high":2.64739,"avg":-2.187931,"sd":2.499936,"marketCap":20621759},"quantilePoints":[{"date":"2020-06-26","current":-6.329984,"twenty":-13.065239,"median":-3.178011,"eighty":-1.592728,"marketCap":422153841},{"date":"2020-07-02","current":-5.903059,"twenty":-13.043545,"median":-3.187953,"eighty":-1.592991,"marketCap":393681727},{"date":"2020-07-10","current":-6.132942,"twenty":-12.853722,"median":-3.193257,"eighty":-1.596361,"marketCap":409012865},{"date":"2020-07-17","current":-5.96874,"twenty":-12.799487,"median":-3.20527,"eighty":-1.601238,"marketCap":398062052},{"date":"2020-07-24","current":-5.435084,"twenty":-12.785928,"median":-3.213654,"eighty":-1.606165,"marketCap":362471910},{"date":"2020-07-31","current":-5.295512,"twenty":-12.596106,"median":-3.21978,"eighty":-1.611092,"marketCap":353163719},{"date":"2020-08-07","current":-5.903059,"twenty":-12.243577,"median":-3.235692,"eighty":-1.61843,"marketCap":393681727},{"date":"2020-08-14","current":-5.61951,"twenty":-10.087731,"median":-3.244285,"eighty":-1.61843,"marketCap":428122777},{"date":"2020-08-21","current":-5.735647,"twenty":-6.494186,"median":-3.26453,"eighty":-1.6308,"marketCap":436970648},{"date":"2020-08-28","current":-4.854822,"twenty":-6.477766,"median":-3.268378,"eighty":-1.635726,"marketCap":369864936},{"date":"2020-09-04","current":-4.555552,"twenty":-6.428505,"median":-3.289968,"eighty":-1.64558,"marketCap":347065042},{"date":"2020-09-11","current":-4.746752,"twenty":-6.415369,"median":-3.296406,"eighty":-1.647401,"marketCap":361631641},{"date":"2020-09-18","current":-5.561431,"twenty":-6.346404,"median":-3.313499,"eighty":-1.656545,"marketCap":423698017},{"date":"2020-09-25","current":-4.842352,"twenty":-6.31028,"median":-3.317454,"eighty":-1.671857,"marketCap":368914940},{"date":"2020-10-02","current":-4.788318,"twenty":-6.213905,"median":-3.328258,"eighty":-1.679083,"marketCap":364798293},{"date":"2020-10-09","current":-4.696874,"twenty":-6.177384,"median":-3.337487,"eighty":-1.68401,"marketCap":357831659},{"date":"2020-10-16","current":-4.588804,"twenty":-6.141147,"median":-3.341501,"eighty":-1.694849,"marketCap":349598364},{"date":"2020-10-23","current":-4.439169,"twenty":-6.126374,"median":-3.357802,"eighty":-1.697591,"marketCap":338198417},{"date":"2020-10-30","current":-4.247969,"twenty":-6.085323,"median":-3.365908,"eighty":-1.699014,"marketCap":323631819},{"date":"2020-11-06","current":-4.1399,"twenty":-6.070351,"median":-3.374349,"eighty":-1.699691,"marketCap":315398524},{"date":"2020-11-13","current":-5.043071,"twenty":-6.067623,"median":-3.38324,"eighty":-1.704146,"marketCap":383148740},{"date":"2020-11-20","current":-5.126565,"twenty":-6.060693,"median":-3.388189,"eighty":-1.716635,"marketCap":389492263},{"date":"2020-11-27","current":-5.251807,"twenty":-6.054125,"median":-3.400199,"eighty":-1.719484,"marketCap":399007546},{"date":"2020-12-04","current":-2.237654,"twenty":-6.050841,"median":-3.397512,"eighty":-1.72506,"marketCap":170006394},{"date":"2020-12-11","current":-2.13746,"twenty":-6.043785,"median":-3.384656,"eighty":-1.730778,"marketCap":162394168},{"date":"2020-12-18","current":-2.212606,"twenty":-6.036285,"median":-3.382048,"eighty":-1.738939,"marketCap":168103338},{"date":"2020-12-24","current":-2.179208,"twenty":-6.025029,"median":-3.374349,"eighty":-1.744811,"marketCap":165565929},{"date":"2020-12-31","current":-1.928724,"twenty":-6.009068,"median":-3.365908,"eighty":-1.746791,"marketCap":146535362},{"date":"2021-01-08","current":-2.020568,"twenty":-6.000093,"median":-3.357802,"eighty":-1.747734,"marketCap":153513237},{"date":"2021-01-15","current":-2.062315,"twenty":-5.989063,"median":-3.341501,"eighty":-1.760204,"marketCap":156684998},{"date":"2021-01-22","current":-2.262702,"twenty":-5.96874,"median":-3.339166,"eighty":-1.794986,"marketCap":171909451},{"date":"2021-01-29","current":-2.346197,"twenty":-5.96874,"median":-3.33263,"eighty":-1.812846,"marketCap":178252973},{"date":"2021-02-05","current":-2.663476,"twenty":-5.954658,"median":-3.320514,"eighty":-1.815132,"marketCap":202358358},{"date":"2021-02-12","current":-2.855514,"twenty":-5.92671,"median":-3.314518,"eighty":-1.818921,"marketCap":216948459},{"date":"2021-02-19","current":-2.897261,"twenty":-5.920925,"median":-3.306927,"eighty":-1.825804,"marketCap":220120220},{"date":"2021-02-26","current":-2.463089,"twenty":-5.912911,"median":-3.291691,"eighty":-1.835035,"marketCap":187133904},{"date":"2021-03-05","current":-3.314734,"twenty":-5.904701,"median":-3.293414,"eighty":-1.850453,"marketCap":251837831},{"date":"2021-03-12","current":-3.423277,"twenty":-5.903059,"median":-3.309703,"eighty":-1.856274,"marketCap":260084410},{"date":"2021-03-19","current":-3.62703,"twenty":-5.890307,"median":-3.314734,"eighty":-1.868955,"marketCap":293918457},{"date":"2021-03-26","current":-3.221322,"twenty":-5.873599,"median":-3.313499,"eighty":-1.881006,"marketCap":261041672},{"date":"2021-04-01","current":-3.302463,"twenty":-5.860098,"median":-3.308752,"eighty":-1.887678,"marketCap":267617029},{"date":"2021-04-09","current":-2.994125,"twenty":-5.828989,"median":-3.296406,"eighty":-1.898454,"marketCap":242630673},{"date":"2021-04-16","current":-3.067153,"twenty":-5.807822,"median":-3.281489,"eighty":-1.904671,"marketCap":248548494},{"date":"2021-04-23","current":-2.977897,"twenty":-5.793302,"median":-3.267519,"eighty":-1.907715,"marketCap":241315601},{"date":"2021-04-30","current":-3.07009,"twenty":-5.782269,"median":-3.26453,"eighty":-1.916612,"marketCap":248786532},{"date":"2021-05-07","current":-2.911148,"twenty":-5.760203,"median":-3.247572,"eighty":-1.925829,"marketCap":235906576},{"date":"2021-05-14","current":2.110836,"twenty":-5.740215,"median":-3.238321,"eighty":-1.916612,"marketCap":242750012},{"date":"2021-05-21","current":2.323099,"twenty":-5.731976,"median":-3.234778,"eighty":-1.887678,"marketCap":267160628},{"date":"2021-05-28","current":2.446919,"twenty":-5.728704,"median":-3.221322,"eighty":-1.847068,"marketCap":281400153},{"date":"2021-06-04","current":2.582531,"twenty":-5.721303,"median":-3.214475,"eighty":-1.816648,"marketCap":296995825},{"date":"2021-06-11","current":2.64739,"twenty":-5.709423,"median":-3.213654,"eighty":-1.748678,"marketCap":304454624},{"date":"2021-06-18","current":2.576635,"twenty":-5.704765,"median":-3.204568,"eighty":-1.730112,"marketCap":296317752},{"date":"2021-06-25","current":2.558947,"twenty":-5.696672,"median":-3.191201,"eighty":-1.701961,"marketCap":294283534},{"date":"2021-07-02","current":2.382061,"twenty":-5.682542,"median":-3.187953,"eighty":-1.689922,"marketCap":273941354},{"date":"2021-07-09","current":2.323099,"twenty":-5.667276,"median":-3.178011,"eighty":-1.662002,"marketCap":267160628},{"date":"2021-07-16","current":2.181591,"twenty":-5.64362,"median":-3.166735,"eighty":-1.631785,"marketCap":250886884},{"date":"2021-07-23","current":2.205175,"twenty":-5.623035,"median":-3.163317,"eighty":-1.60715,"marketCap":253599174},{"date":"2021-07-30","current":2.199279,"twenty":-5.619001,"median":-3.156126,"eighty":-1.592728,"marketCap":252921102},{"date":"2021-08-06","current":2.199279,"twenty":-5.613587,"median":-3.15256,"eighty":-1.57688,"marketCap":252921102},{"date":"2021-08-13","current":2.382061,"twenty":-5.598279,"median":-3.145171,"eighty":-1.571677,"marketCap":273941354},{"date":"2021-08-20","current":1.958215,"twenty":-5.585146,"median":-3.140061,"eighty":-1.55297,"marketCap":238441305},{"date":"2021-08-27","current":1.963794,"twenty":-5.561431,"median":-3.131046,"eighty":-1.529528,"marketCap":239120625},{"date":"2021-09-03","current":1.958215,"twenty":-5.560792,"median":-3.126778,"eighty":-1.522882,"marketCap":238441305},{"date":"2021-09-10","current":1.924742,"twenty":-5.558235,"median":-3.122117,"eighty":-1.512554,"marketCap":234365386},{"date":"2021-09-17","current":1.88011,"twenty":-5.555054,"median":-3.118746,"eighty":-1.497774,"marketCap":228930826},{"date":"2021-09-24","current":1.924742,"twenty":-5.552388,"median":-3.114765,"eighty":-1.482993,"marketCap":234365386},{"date":"2021-10-01","current":1.969373,"twenty":-5.50324,"median":-3.108386,"eighty":-1.47217,"marketCap":239799945},{"date":"2021-10-08","current":2.014005,"twenty":-5.498772,"median":-3.105551,"eighty":-1.460552,"marketCap":245234505},{"date":"2021-10-15","current":2.008426,"twenty":-5.492554,"median":-3.097778,"eighty":-1.451557,"marketCap":244555185},{"date":"2021-10-22","current":2.002847,"twenty":-5.448118,"median":-3.094944,"eighty":-1.443578,"marketCap":243875865},{"date":"2021-10-29","current":1.896847,"twenty":-5.435084,"median":-3.088116,"eighty":-1.43667,"marketCap":230968786},{"date":"2021-11-05","current":2.002847,"twenty":-5.419977,"median":-3.083468,"eighty":-1.427559,"marketCap":243875865},{"date":"2021-11-12","current":1.911659,"twenty":-5.419977,"median":-3.076601,"eighty":-1.419804,"marketCap":242408178},{"date":"2021-11-19","current":1.847221,"twenty":-5.418663,"median":-3.073262,"eighty":-1.405253,"marketCap":234237116},{"date":"2021-11-26","current":1.750564,"twenty":-5.388196,"median":-3.069798,"eighty":-1.401836,"marketCap":221980523},{"date":"2021-12-03","current":1.723715,"twenty":-5.362569,"median":-3.067153,"eighty":-1.393524,"marketCap":218575913},{"date":"2021-12-10","current":1.750564,"twenty":-5.351432,"median":-3.048771,"eighty":-1.383007,"marketCap":221980523},{"date":"2021-12-17","current":1.745194,"twenty":-5.332888,"median":-3.040405,"eighty":-1.379278,"marketCap":221299601},{"date":"2021-12-23","current":1.820372,"twenty":-5.308774,"median":-3.034696,"eighty":-1.370718,"marketCap":230832507},{"date":"2021-12-31","current":1.723715,"twenty":-5.292522,"median":-3.023615,"eighty":-1.360829,"marketCap":218575913},{"date":"2022-01-07","current":1.831189,"twenty":-5.27874,"median":-3.012907,"eighty":-1.353596,"marketCap":232204209},{"date":"2022-01-14","current":1.736855,"twenty":-5.268144,"median":-3.007108,"eighty":-1.344586,"marketCap":220242174},{"date":"2022-01-21","current":1.720208,"twenty":-5.263736,"median":-3.004051,"eighty":-1.338336,"marketCap":218131227},{"date":"2022-01-28","current":1.492697,"twenty":-5.25862,"median":-3.00224,"eighty":-1.331151,"marketCap":189281613},{"date":"2022-02-04","current":1.548187,"twenty":-5.254778,"median":-2.994125,"eighty":-1.318059,"marketCap":196318104},{"date":"2022-02-11","current":1.747953,"twenty":-5.229023,"median":-2.978193,"eighty":-1.309895,"marketCap":221649472},{"date":"2022-02-18","current":1.786797,"twenty":-5.192421,"median":-2.970472,"eighty":-1.305625,"marketCap":226575016},{"date":"2022-02-25","current":1.814542,"twenty":-5.187662,"median":-2.969783,"eighty":-1.299407,"marketCap":230093262},{"date":"2022-03-04","current":1.847837,"twenty":-5.17238,"median":-2.960868,"eighty":-1.292345,"marketCap":234315156},{"date":"2022-03-11","current":1.875582,"twenty":-5.128635,"median":-2.946729,"eighty":-1.281502,"marketCap":237833402},{"date":"2022-03-18","current":1.839041,"twenty":-5.12542,"median":-2.933837,"eighty":-1.267503,"marketCap":225897850},{"date":"2022-03-25","current":1.84477,"twenty":-5.119177,"median":-2.925094,"eighty":-1.258625,"marketCap":226601581},{"date":"2022-04-01","current":1.839041,"twenty":-5.111995,"median":-2.921098,"eighty":-1.243249,"marketCap":225897850},{"date":"2022-04-08","current":1.84477,"twenty":-5.109866,"median":-2.912066,"eighty":-1.232556,"marketCap":226601581},{"date":"2022-04-14","current":1.839041,"twenty":-5.109866,"median":-2.9084,"eighty":-1.221179,"marketCap":225897850},{"date":"2022-04-22","current":1.678626,"twenty":-5.101517,"median":-2.906819,"eighty":-1.206466,"marketCap":206193364},{"date":"2022-04-29","current":1.576492,"twenty":-5.065399,"median":-2.89584,"eighty":-1.184396,"marketCap":193647698},{"date":"2022-05-06","current":1.616621,"twenty":-5.047102,"median":-2.887777,"eighty":-1.175569,"marketCap":198576912},{"date":"2022-05-13","current":-2.225927,"twenty":-5.037348,"median":-2.864933,"eighty":-1.162383,"marketCap":154213985},{"date":"2022-05-20","current":-2.093795,"twenty":-4.983879,"median":-2.845525,"eighty":-1.162383,"marketCap":145059730},{"date":"2022-05-27","current":-1.768545,"twenty":-4.919065,"median":-2.819883,"eighty":-1.162383,"marketCap":122526180},{"date":"2022-06-03","current":-1.971826,"twenty":-4.887514,"median":-2.784964,"eighty":-1.162383,"marketCap":136609649},{"date":"2022-06-10","current":-1.921006,"twenty":-4.809515,"median":-2.763071,"eighty":-1.162383,"marketCap":133088782},{"date":"2022-06-17","current":-1.88035,"twenty":-4.77192,"median":-2.737656,"eighty":-1.162383,"marketCap":130272088},{"date":"2022-06-24","current":-1.941334,"twenty":-4.750077,"median":-2.69655,"eighty":-1.155083,"marketCap":134497128},{"date":"2022-07-01","current":-2.225927,"twenty":-4.72015,"median":-2.663476,"eighty":-1.155083,"marketCap":154213985},{"date":"2022-07-08","current":-2.225927,"twenty":-4.69795,"median":-2.645541,"eighty":-1.155083,"marketCap":154213985},{"date":"2022-07-15","current":-2.053139,"twenty":-4.655198,"median":-2.611624,"eighty":-1.155083,"marketCap":142243036},{"date":"2022-07-22","current":-2.053139,"twenty":-4.595454,"median":-2.596681,"eighty":-1.155083,"marketCap":142243036},{"date":"2022-07-29","current":-2.083631,"twenty":-4.577995,"median":-2.560818,"eighty":-1.155083,"marketCap":144355557},{"date":"2022-08-05","current":-2.236091,"twenty":-4.554159,"median":-2.529885,"eighty":-1.155083,"marketCap":154918159},{"date":"2022-08-12","current":-2.327289,"twenty":-4.532906,"median":-2.496487,"eighty":-1.155083,"marketCap":158443623},{"date":"2022-08-19","current":-2.223854,"twenty":-4.49667,"median":-2.463089,"eighty":-1.155083,"marketCap":151401684},{"date":"2022-08-26","current":-2.21351,"twenty":-4.464109,"median":-2.425085,"eighty":-1.155083,"marketCap":150697490},{"date":"2022-09-02","current":-2.068701,"twenty":-4.439768,"median":-2.385594,"eighty":-1.155083,"marketCap":140838776},{"date":"2022-09-09","current":-2.254885,"twenty":-4.395685,"median":-2.354546,"eighty":-1.155083,"marketCap":153514265},{"date":"2022-09-16","current":-2.151449,"twenty":-4.354193,"median":-2.340271,"eighty":-1.155083,"marketCap":146472327},{"date":"2022-09-23","current":-1.913549,"twenty":-4.315381,"median":-2.327289,"eighty":-1.155083,"marketCap":130275867},{"date":"2022-09-30","current":-1.903205,"twenty":-4.284546,"median":-2.296259,"eighty":-1.155083,"marketCap":129571673},{"date":"2022-10-07","current":-1.79977,"twenty":-4.196575,"median":-2.284356,"eighty":-1.155083,"marketCap":122529735},{"date":"2022-10-14","current":-1.613587,"twenty":-4.003919,"median":-2.265784,"eighty":-1.155083,"marketCap":109854245},{"date":"2022-10-21","current":-1.665305,"twenty":-3.889348,"median":-2.25642,"eighty":-1.155083,"marketCap":113375214},{"date":"2022-10-28","current":-1.685992,"twenty":-3.823683,"median":-2.246256,"eighty":-1.155083,"marketCap":114783602},{"date":"2022-11-04","current":-1.572213,"twenty":-3.797174,"median":-2.237654,"eighty":-1.155083,"marketCap":107037469},{"date":"2022-11-11","current":-1.642004,"twenty":-3.718531,"median":-2.236091,"eighty":-1.155083,"marketCap":112747016},{"date":"2022-11-18","current":-1.703579,"twenty":-3.687034,"median":-2.223854,"eighty":-1.155083,"marketCap":116975029},{"date":"2022-11-25","current":-1.847254,"twenty":-3.665867,"median":-2.219354,"eighty":-1.155083,"marketCap":126840393},{"date":"2022-12-02","current":-1.898567,"twenty":-3.644592,"median":-2.196138,"eighty":-1.155083,"marketCap":130363737},{"date":"2022-12-09","current":-1.867779,"twenty":-3.574214,"median":-2.187557,"eighty":-1.155083,"marketCap":128249730},{"date":"2022-12-16","current":-1.785679,"twenty":-3.528054,"median":-2.179208,"eighty":-1.155083,"marketCap":122612379},{"date":"2022-12-23","current":-1.744629,"twenty":-3.510793,"median":-2.162221,"eighty":-1.155083,"marketCap":119793704},{"date":"2022-12-30","current":-1.908829,"twenty":-3.501328,"median":-2.154159,"eighty":-1.155083,"marketCap":131068406},{"date":"2023-01-06","current":-1.929354,"twenty":-3.496465,"median":-2.151449,"eighty":-1.155083,"marketCap":132477743},{"date":"2023-01-13","current":-2.442481,"twenty":-3.485292,"median":-2.145066,"eighty":-1.155083,"marketCap":167711186},{"date":"2023-01-20","current":-2.36038,"twenty":-3.476513,"median":-2.145066,"eighty":-1.155083,"marketCap":162073835},{"date":"2023-01-27","current":-2.596418,"twenty":-3.465698,"median":-2.145066,"eighty":-1.155083,"marketCap":178281219},{"date":"2023-02-03","current":-2.493793,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":171234530},{"date":"2023-02-10","current":-2.545106,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":174757874},{"date":"2023-02-17","current":-2.575893,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":176871881},{"date":"2023-02-24","current":-2.514318,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":172643868},{"date":"2023-03-03","current":-2.442481,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":167711186},{"date":"2023-03-10","current":-2.052505,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":140933770},{"date":"2023-03-17","current":-2.940994,"twenty":-3.451027,"median":-2.145066,"eighty":-1.155083,"marketCap":159310812},{"date":"2023-03-24","current":-3.409471,"twenty":-3.451027,"median":-2.145066,"eighty":-1.155083,"marketCap":184687756},{"date":"2023-03-31","current":-3.357418,"twenty":-3.472861,"median":-2.145066,"eighty":-1.162383,"marketCap":181868095},{"date":"2023-04-06","current":-3.344405,"twenty":-3.473167,"median":-2.145066,"eighty":-1.162383,"marketCap":181163180},{"date":"2023-04-14","current":-4.021094,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":217818765},{"date":"2023-04-21","current":-3.969041,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":214999105},{"date":"2023-04-28","current":-4.699771,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":254582037},{"date":"2023-05-05","current":-4.751846,"twenty":-3.481817,"median":-2.145066,"eighty":-1.155083,"marketCap":257402891},{"date":"2023-05-12","current":-4.841579,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":248940330},{"date":"2023-05-19","current":-4.74557,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":244003836},{"date":"2023-05-26","current":-4.649561,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":239067342},{"date":"2023-06-02","current":-5.074742,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":260928958},{"date":"2023-06-09","current":-4.814148,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":247529903},{"date":"2023-06-16","current":-4.910156,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":252466397},{"date":"2023-06-23","current":-5.129605,"twenty":-3.482878,"median":-2.144966,"eighty":-1.147784,"marketCap":263749811},{"date":"2023-06-30","current":-4.553553,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":234130848},{"date":"2023-07-07","current":-4.731854,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":243298623},{"date":"2023-07-14","current":-4.676992,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":240477769},{"date":"2023-07-21","current":-4.827863,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":248235116},{"date":"2023-07-28","current":-4.766143,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":245061656},{"date":"2023-08-04","current":-4.553553,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":234130848},{"date":"2023-08-11","current":-5.047451,"twenty":-3.499573,"median":-2.144867,"eighty":-1.140484,"marketCap":248521831},{"date":"2023-08-18","current":-5.448953,"twenty":-3.501743,"median":-2.144867,"eighty":-1.140484,"marketCap":268290613},{"date":"2023-08-25","current":-5.463292,"twenty":-3.517843,"median":-2.144867,"eighty":-1.140484,"marketCap":268996641},{"date":"2023-09-01","current":-4.825191,"twenty":-3.556813,"median":-2.144867,"eighty":-1.140484,"marketCap":237578398},{"date":"2023-09-08","current":-5.133487,"twenty":-3.640374,"median":-2.144867,"eighty":-1.140484,"marketCap":252757998},{"date":"2023-09-15","current":-5.50631,"twenty":-3.703758,"median":-2.144867,"eighty":-1.140484,"marketCap":271114725},{"date":"2023-09-22","current":-5.176505,"twenty":-3.826088,"median":-2.144867,"eighty":-1.140484,"marketCap":254876082},{"date":"2023-09-29","current":-5.405935,"twenty":-3.968328,"median":-2.144867,"eighty":-1.140484,"marketCap":266172529},{"date":"2023-10-06","current":-5.119148,"twenty":-4.056089,"median":-2.144867,"eighty":-1.140484,"marketCap":252051971},{"date":"2023-10-13","current":-5.162166,"twenty":-4.177514,"median":-2.144867,"eighty":-1.140484,"marketCap":254170054},{"date":"2023-10-20","current":-5.07613,"twenty":-4.274571,"median":-2.144867,"eighty":-1.140484,"marketCap":249933887},{"date":"2023-10-27","current":-4.918397,"twenty":-4.28993,"median":-2.139283,"eighty":-1.0445,"marketCap":242167579},{"date":"2023-11-03","current":-5.06179,"twenty":-4.337304,"median":-2.139283,"eighty":-1.0445,"marketCap":249227859},{"date":"2023-11-10","current":-4.617672,"twenty":-4.387475,"median":-2.139283,"eighty":-1.0445,"marketCap":224057346},{"date":"2023-11-17","current":-4.76334,"twenty":-4.445819,"median":-2.139283,"eighty":-1.0445,"marketCap":231125401},{"date":"2023-11-24","current":-4.85074,"twenty":-4.464982,"median":-2.145438,"eighty":-1.0445,"marketCap":235366234},{"date":"2023-12-01","current":-4.333619,"twenty":-4.472069,"median":-2.15395,"eighty":-1.0445,"marketCap":210274639},{"date":"2023-12-08","current":-4.967275,"twenty":-4.532458,"median":-2.162221,"eighty":-1.088842,"marketCap":241020678},{"date":"2023-12-15","current":-4.952708,"twenty":-4.558877,"median":-2.179208,"eighty":-1.088842,"marketCap":240313873},{"date":"2023-12-22","current":-5.083809,"twenty":-4.606027,"median":-2.187557,"eighty":-1.088842,"marketCap":246675122},{"date":"2023-12-29","current":-4.872591,"twenty":-4.625922,"median":-2.195435,"eighty":-1.0445,"marketCap":236426443},{"date":"2024-01-05","current":-4.603105,"twenty":-4.642381,"median":-2.204256,"eighty":-1.000158,"marketCap":223350541},{"date":"2024-01-12","current":-4.559405,"twenty":-4.648459,"median":-2.219354,"eighty":-1.000158,"marketCap":221230124},{"date":"2024-01-19","current":-4.573971,"twenty":-4.64901,"median":-2.225927,"eighty":-0.955816,"marketCap":221936930},{"date":"2024-01-26","current":-5.244044,"twenty":-4.655235,"median":-2.236091,"eighty":-1.000158,"marketCap":254449983},{"date":"2024-02-02","current":-5.637347,"twenty":-4.663277,"median":-2.244541,"eighty":-1.000158,"marketCap":273533732},{"date":"2024-02-09","current":-5.462545,"twenty":-4.676992,"median":-2.254885,"eighty":-1.000158,"marketCap":265052066},{"date":"2024-02-16","current":-5.302311,"twenty":-4.698612,"median":-2.265228,"eighty":-1.014758,"marketCap":257277205},{"date":"2024-02-23","current":-5.360578,"twenty":-4.704812,"median":-2.275572,"eighty":-1.172626,"marketCap":260104427},{"date":"2024-03-01","current":-4.952708,"twenty":-4.730126,"median":-2.294047,"eighty":-1.174097,"marketCap":240313873},{"date":"2024-03-08","current":-4.617672,"twenty":-4.731854,"median":-2.30861,"eighty":-1.174097,"marketCap":224057346},{"date":"2024-03-15","current":-3.715246,"twenty":-4.731854,"median":-2.33774,"eighty":-1.174097,"marketCap":194452106},{"date":"2024-03-22","current":-4.120546,"twenty":-4.731854,"median":-2.344029,"eighty":-1.174097,"marketCap":215665063},{"date":"2024-03-28","current":-4.120546,"twenty":-4.731854,"median":-2.357463,"eighty":-1.174097,"marketCap":215665063},{"date":"2024-04-05","current":-4.120546,"twenty":-4.731854,"median":-2.40143,"eighty":-1.172626,"marketCap":215665063},{"date":"2024-04-12","current":-4.417765,"twenty":-4.731854,"median":-2.423645,"eighty":-1.172626,"marketCap":231221232},{"date":"2024-04-19","current":-4.336705,"twenty":-4.731854,"median":-2.442481,"eighty":-1.172626,"marketCap":226978640},{"date":"2024-04-26","current":-4.045244,"twenty":-4.731854,"median":-2.459275,"eighty":-1.174097,"marketCap":211723876},{"date":"2024-05-03","current":-4.153478,"twenty":-4.731854,"median":-2.463048,"eighty":-1.174097,"marketCap":217388729},{"date":"2024-05-10","current":-4.12642,"twenty":-4.731854,"median":-2.477117,"eighty":-1.174097,"marketCap":215972516},{"date":"2024-05-17","current":-4.584799,"twenty":-4.731854,"median":-2.500272,"eighty":-1.174097,"marketCap":232343653},{"date":"2024-05-24","current":-4.213815,"twenty":-4.731854,"median":-2.517501,"eighty":-1.174097,"marketCap":213543327},{"date":"2024-05-31","current":-4.283812,"twenty":-4.731854,"median":-2.532364,"eighty":-1.17704,"marketCap":217090558},{"date":"2024-06-07","current":-4.339809,"twenty":-4.731854,"median":-2.554718,"eighty":-1.194696,"marketCap":219928343},{"date":"2024-06-14","current":-4.479803,"twenty":-4.731854,"median":-2.565631,"eighty":-1.262647,"marketCap":227022806},{"date":"2024-06-21","current":-0.981357,"twenty":-4.731854,"median":-2.565631,"eighty":-1.005688,"marketCap":49732183},{"date":"2024-06-28","current":-1.016915,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":51534177},{"date":"2024-07-05","current":-1.052334,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":53329076},{"date":"2024-07-12","current":-1.328542,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":67326451},{"date":"2024-07-15","current":-1.334701,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":67638607},{"date":"2024-08-02","current":-1.385799,"twenty":-4.734206,"median":-2.596418,"eighty":1.509344,"marketCap":70228086},{"date":"2024-08-09","current":-1.280944,"twenty":-4.734206,"median":-2.596418,"eighty":1.509344,"marketCap":64914333},{"date":"2024-08-16","current":-2.695912,"twenty":-4.734206,"median":-2.59655,"eighty":1.509344,"marketCap":80197882},{"date":"2024-08-23","current":-2.886773,"twenty":-4.734206,"median":-2.613367,"eighty":1.509344,"marketCap":85875608},{"date":"2024-08-30","current":-2.862915,"twenty":-4.734206,"median":-2.650334,"eighty":1.509344,"marketCap":85165892},{"date":"2024-09-06","current":-2.71977,"twenty":-4.734206,"median":-2.661824,"eighty":1.509344,"marketCap":80907597},{"date":"2024-09-13","current":-2.648197,"twenty":-4.734206,"median":-2.667765,"eighty":1.509344,"marketCap":78778450},{"date":"2024-09-20","current":-2.791343,"twenty":-4.734206,"median":-2.695912,"eighty":1.509344,"marketCap":83036745},{"date":"2024-09-27","current":-2.672054,"twenty":-4.734206,"median":-2.695912,"eighty":1.509344,"marketCap":79488166},{"date":"2024-10-04","current":-2.695912,"twenty":-4.734206,"median":-2.696483,"eighty":1.509344,"marketCap":80197882},{"date":"2024-10-11","current":-2.600482,"twenty":-4.734206,"median":-2.701653,"eighty":1.509344,"marketCap":77359018},{"date":"2024-10-18","current":-2.791343,"twenty":-4.734206,"median":-2.71977,"eighty":1.509344,"marketCap":83036745},{"date":"2024-10-25","current":-2.886773,"twenty":-4.734206,"median":-2.743627,"eighty":1.509344,"marketCap":85875608},{"date":"2024-10-31","current":-2.743627,"twenty":-4.734206,"median":-2.77273,"eighty":1.509344,"marketCap":81617313},{"date":"2024-11-08","current":-3.101492,"twenty":-4.734206,"median":-2.791343,"eighty":1.510454,"marketCap":92263050},{"date":"2024-11-15","current":-2.512505,"twenty":-4.734206,"median":-2.797849,"eighty":1.510454,"marketCap":81661345},{"date":"2024-11-22","current":-2.315874,"twenty":-4.734206,"median":-2.797849,"eighty":1.510454,"marketCap":75270457},{"date":"2024-11-29","current":-2.490657,"twenty":-4.734206,"median":-2.791343,"eighty":1.510454,"marketCap":80951247},{"date":"2024-12-06","current":-2.250331,"twenty":-4.734206,"median":-2.78121,"eighty":1.510454,"marketCap":73140161},{"date":"2024-12-13","current":-2.315874,"twenty":-4.734206,"median":-2.743627,"eighty":1.510454,"marketCap":75270457},{"date":"2024-12-20","current":-2.228483,"twenty":-4.734206,"median":-2.71977,"eighty":1.510454,"marketCap":72430063},{"date":"2024-12-27","current":-2.180636,"twenty":-4.734206,"median":-2.719769,"eighty":1.510454,"marketCap":70874947},{"date":"2025-01-03","current":-2.093026,"twenty":-4.734206,"median":-2.696417,"eighty":1.510454,"marketCap":68027451},{"date":"2025-01-10","current":-1.987938,"twenty":-4.734206,"median":-2.695912,"eighty":1.511564,"marketCap":64611877},{"date":"2025-01-17","current":-1.594895,"twenty":-4.734206,"median":-2.672054,"eighty":1.511564,"marketCap":51837202},{"date":"2025-01-24","current":-1.550762,"twenty":-4.734206,"median":-2.668747,"eighty":1.511564,"marketCap":50402802},{"date":"2025-01-31","current":-1.52957,"twenty":-4.734206,"median":-2.648197,"eighty":1.511564,"marketCap":49714007},{"date":"2025-02-07","current":-1.522797,"twenty":-4.734206,"median":-2.615387,"eighty":1.511564,"marketCap":49493876},{"date":"2025-02-14","current":-1.410717,"twenty":-4.734206,"median":-2.603272,"eighty":1.511564,"marketCap":45851070},{"date":"2025-02-21","current":-1.238774,"twenty":-4.734206,"median":-2.59655,"eighty":1.511564,"marketCap":40262594},{"date":"2025-02-28","current":-1.160777,"twenty":-4.734206,"median":-2.583439,"eighty":1.511564,"marketCap":37727541},{"date":"2025-03-07","current":-1.133031,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":36825716},{"date":"2025-03-14","current":-1.183105,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":31273002},{"date":"2025-03-21","current":-1.157829,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":30604897},{"date":"2025-03-28","current":-1.018814,"twenty":-4.734206,"median":-2.560818,"eighty":1.512673,"marketCap":26930319},{"date":"2025-04-04","current":-0.810427,"twenty":-4.734206,"median":-2.552766,"eighty":1.512673,"marketCap":21422006},{"date":"2025-04-11","current":-0.685663,"twenty":-4.734206,"median":-2.539975,"eighty":1.511564,"marketCap":18124126},{"date":"2025-04-17","current":-0.728416,"twenty":-4.734206,"median":-2.517501,"eighty":1.511564,"marketCap":19254218},{"date":"2025-04-25","current":-0.905613,"twenty":-4.734206,"median":-2.504056,"eighty":1.512673,"marketCap":23938061},{"date":"2025-05-02","current":-0.847533,"twenty":-4.734206,"median":-2.490657,"eighty":1.512673,"marketCap":22402841},{"date":"2025-05-09","current":-0.790529,"twenty":-4.734206,"median":-2.471439,"eighty":1.512673,"marketCap":20896051},{"date":"2025-05-16","current":-0.869293,"twenty":-4.734206,"median":-2.463006,"eighty":1.512673,"marketCap":21709734},{"date":"2025-05-23","current":-0.816333,"twenty":-4.733318,"median":-2.442481,"eighty":1.512673,"marketCap":20387097},{"date":"2025-05-30","current":-0.856765,"twenty":-4.731933,"median":-2.432218,"eighty":1.512673,"marketCap":21396852},{"date":"2025-06-06","current":-0.892072,"twenty":-4.731933,"median":-2.40143,"eighty":1.512673,"marketCap":22278610},{"date":"2025-06-13","current":-0.823736,"twenty":-4.731933,"median":-2.354546,"eighty":1.512673,"marketCap":20571982},{"date":"2025-06-20","current":-0.842528,"twenty":-4.731854,"median":-2.337847,"eighty":1.513783,"marketCap":21041305},{"date":"2025-06-24","current":-0.825729,"twenty":-4.730126,"median":-2.332461,"eighty":1.513783,"marketCap":20621759}],"updateTime":1750892331789}}}